ESR1 activating variants
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | ER positive, ESR1 activating variants, HER2-negative | Invasive Breast Carcinoma | Elacestrant | |
| FDA (1) | ER positive, ESR1 activating variants, HER2-negative | Invasive Breast Carcinoma | Imlunestrant |